首页> 外文期刊>Cell death & disease. >Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
【24h】

Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma

机译:同种型特异性FBXW7介导的Notch1突发突变C1133Y口腔鳞状细胞癌中的放松管制

获取原文
           

摘要

Our group previously identified that the NOTCH1 Abruptex domain contains the most mutations in Chinese OSCC patients, including a hotspot mutation (C1133Y). FBXW7 is an E3 ubiquitin ligase that regulates a network of proteins, including NOTCH1, via degradation. In this study, we first described the co-localization of isoform specific FBXW7-FBXW7β and NOTCH1C1133Y mutation in the same cytoplasmic sites. Gain- and loss-of-function assays were performed to examine the tumor suppressor role of FBXW7β in the proliferation and invasion of OSCC cells. The co-expression of NOTCH1C1133Y and FBXW7β significantly attenuated tumor growth. Meanwhile, FBXW7β reversed the oncogenic phenotype and the activation of the AKT/ERK/NFκB pathway induced by NOTCH1C1133Y mutation. FBXW7β downregulated the stability of NOTCH1C1133Y protein and promoted protein ubiquitination. This was the first time that we selected a NOTCH1 hotspot mutation detected in clinical samples and identified the function of FBXW7β that mediated NOTCH1 mutation degradation in OSCC. The newly identified interaction between FBXW7β and NOTCH1C1133Y protein provides new insights into the progression of OSCC, especially regarding Abruptex domain mutations, and represents a valuable target for OSCC therapy.
机译:我们的小组以前确定了Notch1 Quistex结构域包含中国OSCC患者中最多的突变,包括热点突变(C1133Y)。 FBXW7是一种E3泛素连接酶,其通过降解调节包括Notch1的蛋白质网络。在这项研究中,首先描述了同种型特异性FBXW7-FBXW7β和Notch1C1133Y在同一细胞质位点的共定位。进行增益和函数丧失测定以检查FBXW7β在OSCC细胞增殖中FBXW7β的肿瘤抑制作用。 Notch1C1133Y和FBXW7β的共表达显着减弱了肿瘤生长。同时,FBXW7β反转了Notch1C1133Y突变诱导的致癌表型和Akt / Erk /NFκB途径的激活。 FBXW7β下调了Notch1C1133Y蛋白的稳定性,促进了蛋白质泛素。这是我们第一次选择在临床样品中检测到的Notch1热点突变,并确定了介导的Notch1突变降解在OSCC中的FBXW7β的功能。 FBXW7β和Notch1C1133Y蛋白质的新发现的相互作用为OSCC的进展提供了新的见解,特别是关于突发结构域突变,并且代表了OSCC治疗的有价值的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号